Oncology Venture ApS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Oncology Venture ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014277
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB is a drug development company that discovers new oncology products, and rescuing failed ones. The company provides gene-tumor-technology for identifying patients with resistance to anticancer drug. Its activities include in-licensing drugs with low response rate performing phase II trials on a selected population and identifying the ones that are positive for its proprietary biomarker; and out-licensing the drugs with high response rate. Oncology Venture conducts research and development to discover new drugs. The company partners with other pharmaceutical companies to co-develop oncology drugs. Oncology Venture is headquartered in Hoersholm, Denmark.

Oncology Venture ApS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Oncology Venture ApS, Medical Devices Deals, 2011 to YTD 2017 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Oncology Venture Raises USD0.56 Million in Venture Financing 11
Licensing Agreements 12
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 12
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 13
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 14
Equity Offering 15
Oncology Venture Raises USD1 Million in Private Placement of Shares 15
Oncology Venture ApS – Key Competitors 16
Oncology Venture ApS – Key Employees 17
Oncology Venture ApS – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Oncology Venture ApS, Pharmaceuticals & Healthcare, Key Facts 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oncology Venture ApS, Deals By Therapy Area, 2011 to YTD 2017 8
Oncology Venture ApS, Medical Devices Deals, 2011 to YTD 2017 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oncology Venture Raises USD0.56 Million in Venture Financing 11
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 12
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 13
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 14
Oncology Venture Raises USD1 Million in Private Placement of Shares 15
Oncology Venture ApS, Key Competitors 16
Oncology Venture ApS, Key Employees 17

★海外企業調査レポート[Oncology Venture ApS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Norinchukin Bank:企業の戦略・SWOT・財務分析
    The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report Summary The Norinchukin Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Davos Life Science Pte Ltd:企業の戦略・SWOT・財務情報
    Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report Summary Davos Life Science Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ortho-Clinical Diagnostics Inc:企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Lake Country Power:企業の戦略的SWOT分析
    Lake Country Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • CellaVision AB (CEVI)-医療機器分野:企業M&A・提携分析
    Summary CellaVision AB (CellaVision) is a medical technology company that provides digital solutions for medical microscopy in hematology. The company helps hematology laboratories improve and transform the analysis of blood and other body fluids. It has expertise in digital image analysis, automate …
  • Adira Energy Ltd (ADENF):石油・ガス:M&Aディール及び事業提携情報
    Summary Adira Energy Ltd (Adira Energy) is an oil and gas company that acquires and explores crude oil and natural gas resource properties. The company undertakes oil and gas projects across Israel. It also holds interest in three offshore petroleum projects in Yitzhak, Gabriella, and Samuel. Adira …
  • Venoco, LLC-石油・ガス分野:企業M&A・提携分析
    Summary Venoco, LLC (Venoco), formerly known as Venoco, Inc., is an independent energy company. It carries out acquisition, exploration, exploitation and development of oil and natural gas properties. The company’s major onshore and offshore properties are located in Southern California. Venoco offs …
  • Petroleo Brasileiro SA (PETR4)-石油・ガス分野:企業M&A・提携分析
    Summary Petroleo Brasileiro S.A. (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing , trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical-gas busin …
  • Myriad Group AG:企業の戦略的SWOT分析
    Myriad Group AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • PeptiDream Inc (4587):製薬・医療:M&Aディール及び事業提携情報
    Summary PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produ …
  • Forge Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Forge Energy LLC (Forge Energy) is an independent oil and gas exploration and production company that acquires, explores, operates, manages, produces and develops natural oil and gas properties. The company offers services such as consolidation, acquisition, leasing, and exploitation of matu …
  • Plains All American Pipeline LP (PAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Plains All American Pipeline LP (PAAP) is a midstream energy company. It owns and operates the transportation, storage, terminalling and marketing of crude oil and refined petroleum products. The company also carries out the storage of natural gas, and processing, transportation, fractionati …
  • Staatsolie Maatschappij Suriname NV:企業の戦略的SWOT分析
    Staatsolie Maatschappij Suriname NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • ContourGlobal plc (GLO):企業の財務・戦略的SWOT分析
    ContourGlobal plc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Leap Therapeutics Inc (LPTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The company’s pipeline products include DKN-01, a humanized monoclonal antibody that targets the D …
  • Nahar Industrial Enterprises Limited (NAHARINDUS):企業の財務・戦略的SWOT分析
    Nahar Industrial Enterprises Limited (NAHARINDUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Brioche Pasquier S.A.:企業の戦略・SWOT・財務分析
    Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report Summary Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SRI International-医療機器分野:企業M&A・提携分析
    Summary SRI International (SRI) is a research institute which provides commercial research and development programs. It conducts research and development in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economi …
  • Finance Wales plc:企業のM&A・事業提携・投資動向
    Finance Wales plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Finance Wales plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆